Premium
COVID‐19 vaccine inquiries regarding children ages 5–11 years received by NIP‐INFO
Author(s) -
Hall Elisha,
Morales Sarah,
Wolicki JoEllen,
Schillie Sarah
Publication year - 2022
Publication title -
public health nursing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.471
H-Index - 55
eISSN - 1525-1446
pISSN - 0737-1209
DOI - 10.1111/phn.13079
Subject(s) - vaccination , immunization , medicine , family medicine , pandemic , vaccination schedule , covid-19 , health care , pediatrics , disease , immunology , infectious disease (medical specialty) , political science , pathology , antigen , law
We describe COVID‐19 immunization inquiries regarding children age 5–11 years received by NIP‐INFO, the Centers for Disease Control and Prevention's (CDC's) e‐mail immunization inquiry service for health care professionals, at the launch of vaccination efforts for this age group, using descriptive qualitative analysis. From November 2 through November 30, 2021, NIP‐INFO responded to 154 questions regarding COVID‐19 vaccination for 5–11‐year‐old children. The most common questions related to formulation and dosage (39.6%), vaccination schedule (14.3%), CDC's educational materials for health care professionals (9.1%), and vaccine safety (8.4%); 16.2% of questions across all inquiry categories related to a vaccination error. We discuss CDC guidance related to the most common inquiries to inform further pediatric COVID‐19 vaccination efforts, including future vaccination of younger pediatric age groups, which will be important to help to curb this pandemic.